VERVE THERAPEUTICS INC

CUSIP: 92539P101 Class: Common Stock

Casdin Capital, LLC's Holding History (CIK: 0001534261)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 4,095,571 Value ($000) $45,993 Avg Close — Range —
Q1 2025
Shares 3,995,571 Value ($000) $18,260 Avg Close — Range —
Q4 2024
Shares 3,995,571 Value ($000) $22,535 Avg Close — Range —
Q3 2024
Shares 3,995,571 Value ($000) $19,339 Avg Close — Range —
Q2 2024
Shares 3,059,094 Value ($000) $14,928 Avg Close — Range —
Q1 2024
Shares 3,059,094 Value ($000) $40,625 Avg Close — Range —
Q4 2023
Shares 3,009,094 Value ($000) $41,947 Avg Close — Range —
Q3 2023
Shares 2,954,710 Value ($000) $39,179 Avg Close — Range —
Q2 2023
Shares 2,360,571 Value ($000) $44,261 Avg Close — Range —
Q1 2023
Shares 2,120,571 Value ($000) $30,579 Avg Close — Range —
Q4 2022
Shares 2,290,571 Value ($000) $44,323 Avg Close — Range —
Q3 2022
Shares 3,178,167 Value ($000) $109,170 Avg Close — Range —
Q2 2022
Shares 3,138,167 Value ($000) $47,951 Avg Close — Range —
Q1 2022
Shares 3,138,167 Value ($000) $71,613 Avg Close — Range —
Q4 2021
Shares 3,138,167 Value ($000) $115,704 Avg Close — Range —
Q3 2021
Shares 3,038,167 Value ($000) $142,794 Avg Close — Range —
Q2 2021
Shares 3,038,167 Value ($000) $183,050 Avg Close — Range —